DK2046943T3 - Mælkesyrebakterie isoleret fra modermælk med probiotisk aktivitet og inhibitorisk aktivitet over for stigning i legemsvægt - Google Patents

Mælkesyrebakterie isoleret fra modermælk med probiotisk aktivitet og inhibitorisk aktivitet over for stigning i legemsvægt

Info

Publication number
DK2046943T3
DK2046943T3 DK07746512.8T DK07746512T DK2046943T3 DK 2046943 T3 DK2046943 T3 DK 2046943T3 DK 07746512 T DK07746512 T DK 07746512T DK 2046943 T3 DK2046943 T3 DK 2046943T3
Authority
DK
Denmark
Prior art keywords
probiotic
lactic acid
body weight
inhibitory activity
acid bacteria
Prior art date
Application number
DK07746512.8T
Other languages
English (en)
Inventor
Ji Hee Kang
Byeung Il You
Sung Il Yun
Han Oh Park
Original Assignee
Bioneer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioneer Corp filed Critical Bioneer Corp
Application granted granted Critical
Publication of DK2046943T3 publication Critical patent/DK2046943T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/145—Gasseri
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
DK07746512.8T 2006-08-04 2007-05-14 Mælkesyrebakterie isoleret fra modermælk med probiotisk aktivitet og inhibitorisk aktivitet over for stigning i legemsvægt DK2046943T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20060073722 2006-08-04
PCT/KR2007/002363 WO2008016214A1 (en) 2006-08-04 2007-05-14 Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation

Publications (1)

Publication Number Publication Date
DK2046943T3 true DK2046943T3 (da) 2013-09-23

Family

ID=38997371

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07746512.8T DK2046943T3 (da) 2006-08-04 2007-05-14 Mælkesyrebakterie isoleret fra modermælk med probiotisk aktivitet og inhibitorisk aktivitet over for stigning i legemsvægt

Country Status (7)

Country Link
US (3) USRE46912E1 (da)
EP (1) EP2046943B1 (da)
JP (1) JP5081242B2 (da)
KR (1) KR101108428B1 (da)
CN (1) CN101541947B (da)
DK (1) DK2046943T3 (da)
WO (1) WO2008016214A1 (da)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1973406B1 (en) 2005-12-28 2014-03-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
USRE46912E1 (en) * 2006-08-04 2018-06-26 Bioneer Corporation Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation
WO2008076975A1 (en) 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
EP1987726A1 (en) * 2007-05-01 2008-11-05 Friesland Brands B.V. Good tasting food product containing a neutralisation agent for adverse compounds
EE05340B1 (et) * 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Tensia DSM 21380 ja selle kasutamine antimikroobse ning verer?hku alandava probiootikuna ning ravimi valmistamiseks ning toiduaine realiseerimisaja pikendamiseks ja toiduaines kontamineerivatemi
US9474773B2 (en) * 2009-02-18 2016-10-25 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
CA2986751A1 (en) 2009-03-27 2010-09-30 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
US9426999B2 (en) * 2009-03-30 2016-08-30 Meiji Co., Ltd. Method for culturing lactic acid bacterium and method for producing fermented milk
EP2415858B1 (en) * 2009-03-30 2017-08-23 Meiji Co., Ltd. Method for producing fermented milk
EP2248908A1 (en) * 2009-05-05 2010-11-10 Eurolactis Group S.A. Probiotic microorganisms isolated from donkey milk
ES2643148T3 (es) 2009-05-26 2017-11-21 Advanced Bionutrition Corporation Composición en polvo seco estable que comprende microorganismos biológicamente activos y/o materiales bioactivos y métodos de producción
CN104784219A (zh) 2009-06-19 2015-07-22 杜邦营养生物科学有限公司 治疗糖尿病及相关病症的双歧杆菌
EA201270085A1 (ru) * 2009-06-30 2012-06-29 Кр. Хансен А/С Способ получения ферментированного молочного продукта
BG110506A (bg) 2009-10-27 2011-05-31 "Селур Вк Холдинг" Еоод Нови щамове млечно-кисели бактерии и техни комбинации за получаване на пробиотични препарати
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
BR112012018839B1 (pt) 2010-01-28 2020-04-14 Advanced Bionutrition Corp composição vítrea seca compreendendo um material bioativo
JP5923238B2 (ja) * 2010-07-07 2016-05-24 アサヒグループホールディングス株式会社 迷走神経活性化剤
BR112013003244B1 (pt) 2010-08-13 2018-07-17 Advanced Bionutrition Corp composição seca estabilizante para material biológico, seu método de preparação, e formulação de carreamento oral
KR101249824B1 (ko) * 2010-12-16 2013-04-03 대상에프앤에프 주식회사 대사증후군 예방에 효과가 있는 식물성유산균 락토바실러스 플란타륨 ｄｓｒ ｊ1―8 및 이의 용도
CN102169034B (zh) * 2011-01-24 2012-04-18 吉林大学 装载机传动轴的扭矩快速测量装置
SG10201600578UA (en) * 2011-01-25 2016-02-26 Meiji Co Ltd Gastrin Production Inhibitor and Food Composition Comprising Same
US20130330308A1 (en) 2011-02-18 2013-12-12 Dupont Nutrition Biosciences Aps Feed additive composition
GB201102857D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
GB201102865D0 (en) 2011-02-18 2011-04-06 Danisco Feed additive composition
EE05750B1 (et) * 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
CN102551046B (zh) * 2011-12-16 2014-07-16 无限极（中国）有限公司 一种天然减肥保健组合物及其应用
GB201213801D0 (en) 2012-08-03 2012-09-12 Dupont Nutrition Biosci Aps Feed additive composition
KR101444216B1 (ko) 2012-11-20 2014-09-26 대한민국 세포외 다당생성 활성을 나타내는 프로바이오틱 락토바실러스브레비스 jsb22 균주
KR101636014B1 (ko) * 2014-07-24 2016-07-04 수원대학교산학협력단 항바이러스 및 항세균 활성을 갖는 락토바실러스 및 그의 용도
EP3185877B1 (en) * 2014-08-29 2020-04-01 Muhammed Majeed Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
KR102125548B1 (ko) 2015-02-10 2020-06-24 주식회사 지니스 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물
KR101664310B1 (ko) * 2015-02-16 2016-10-10 (주)케비젠 공액리놀레산을 생산하는 락토바실러스 가세리 cbg-c20 균주 및 이의 용도
PT3328215T (pt) 2015-07-29 2021-08-03 Advanced Bionutrition Corp Composições probióticas estáveis secas para utilizações dietéticas especiais
BE1023757B1 (nl) * 2016-06-30 2017-07-12 Yun NV Bewaring van micro-organismen
WO2018112740A1 (zh) * 2016-12-20 2018-06-28 深圳华大基因研究院 一种加氏乳杆菌及其培养方法和应用
MY197201A (en) 2017-02-10 2023-05-31 Perfect China Co Ltd Novel probiotics bifidobacteria strains
US10780135B2 (en) * 2018-04-05 2020-09-22 Hooman M. MELAMED Probiotic formulation and method for weight loss treatment
CN108517347B (zh) * 2018-04-12 2020-08-04 江南大学 一种Bacteroides cellulosilyticus的筛选培养基及其应用
EP3817565A1 (en) * 2018-07-05 2021-05-12 DuPont Nutrition Biosciences ApS Use of glucosyl transferase to provide improved texture in fermented milk based products
KR102063554B1 (ko) 2018-09-12 2020-01-09 (주)성운파마코피아 항진균 활성 또는 항균 활성을 갖는 락토바실러스 가세리 swpm102
CN111281894B (zh) * 2018-12-07 2022-03-25 深圳华大生命科学研究院 加氏乳杆菌在预防和/或治疗代谢性疾病中的用途和组合物
CN109511821A (zh) * 2019-01-10 2019-03-26 杨婧芳 一种防治禽流感饲料添加剂及其制备方法
CN110596227B (zh) * 2019-08-08 2021-11-23 河北省食品检验研究院（国家果类及农副加工产品质量监督检验中心、河北省食品安全实验室） 飞行时间质谱即用型斯坦利沙门氏菌定性标准样品的制备方法
KR102266852B1 (ko) * 2019-12-12 2021-06-18 대한민국 항균 활성을 가지는 박테리오신을 생산하는 락토바실러스 가세리 g2 균주
CN111518724B (zh) * 2020-01-19 2021-04-06 河北医科大学 格氏乳杆菌hmv18及其外泌蛋白和应用
JP7410336B2 (ja) * 2020-02-17 2024-01-09 エースバイオメ インコーポレイテッド ラクトバチルス・ガセリｂｎｒ１７を含む更年期疾患治療用組成物
KR102567790B1 (ko) * 2021-01-11 2023-08-17 (주)지에프씨생명과학 알코올 대사 효소 활성을 갖는 락토바실러스 가세리 gfc_1220(gfc_ejr_joy) 균주 및 이를 유효성분으로 포함하는 식품 조성물
CN115039884B (zh) * 2021-05-14 2023-11-03 江苏艾兰得营养品有限公司 一种具有抑制奇异变形杆菌生长作用的鼠李糖乳杆菌及其益生菌组合物、发酵液和应用
CN114409824B (zh) * 2022-02-23 2022-11-15 皖南医学院 毛霉胞外多糖及其制备方法和应用
CN117925484B (zh) * 2024-03-19 2024-07-09 山东中科嘉亿生物工程有限公司 一株改善睡眠呼吸暂停的罗伊氏粘液乳杆菌jylb-101及其产品和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2261372A (en) 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
JP3046303B1 (ja) * 1999-06-24 2000-05-29 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品
KR100753012B1 (ko) 1999-08-03 2007-08-30 가부시키가이샤 야쿠루트 혼샤 발효유 음식품 및 그의 제조방법
JP4580542B2 (ja) 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
WO2004003235A2 (en) * 2002-06-28 2004-01-08 Puleva Biotech, S.A. Probiotic strains, a process for the selection of them, compositions thereof, and their use
US6942857B2 (en) 2002-08-09 2005-09-13 Bioneer Corporation Microorganisms for preventing and/or treating obesity or diabetes mellitus
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
JP5084093B2 (ja) 2003-09-11 2012-11-28 忠夫 齋藤 ガセリシンａの生産方法、抗菌剤及び炎症の治療剤
US7001756B1 (en) 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
USRE46912E1 (en) * 2006-08-04 2018-06-26 Bioneer Corporation Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation

Also Published As

Publication number Publication date
US8309076B2 (en) 2012-11-13
KR20080110447A (ko) 2008-12-18
USRE48652E1 (en) 2021-07-20
USRE46912E1 (en) 2018-06-26
JP5081242B2 (ja) 2012-11-28
CN101541947B (zh) 2013-03-13
CN101541947A (zh) 2009-09-23
US20100203025A1 (en) 2010-08-12
JP2009545311A (ja) 2009-12-24
EP2046943A4 (en) 2010-09-22
WO2008016214A1 (en) 2008-02-07
EP2046943B1 (en) 2013-06-19
EP2046943A1 (en) 2009-04-15
KR101108428B1 (ko) 2012-01-31

Similar Documents

Publication Publication Date Title
DK2046943T3 (da) Mælkesyrebakterie isoleret fra modermælk med probiotisk aktivitet og inhibitorisk aktivitet over for stigning i legemsvægt
HK1125840A1 (en) Use of selected lactic acid bacteria for reducing infantile colic
EP2376660A4 (en) MILKY ACID BACTERIA AND ITS USE IN PROBIOTICS FOR PIGS
EP2407532A4 (en) ISOLATION, IDENTIFICATION AND CHARACTERIZATION OF TRIBES WITH PROBIOTIC ACTIVITY FROM CHAIR SAMPLES OF INFANTLY SUTURED WITH MUTTER MILK
EP2229432A4 (en) ANTIMICROBIAL ACTIVITY OF BACTERIOCIN-PRODUCING LACTIC ACID BACTERIA
GB2465291B (en) Human pluripotent stem cells and their medical use
EP2593187A4 (en) METHODS AND COMPOSITIONS COMPRISING SPORTS-CREATING BACTERIA FOR ENHANCING ANIMAL HEALTH
EP2046352A4 (en) FERMENTED MILK PRODUCT AND ITS USE
IL202386A0 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
EP2142635A4 (en) NOVEL INSULATED BACTERIA FROM FRESH HONEY OR HONEYBONE PRODUCTION PATHWAY
PL2277524T3 (pl) Leczenie IBS z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia
ZA201003978B (en) Composition for human and/or animal nutrition, uses thereof and yeasts
ZA200905797B (en) Use of lactic acid bacteria for improving food lysine absorption of pet animals
EP2112219A4 (en) NEW LACTIC ACID BACTERIA
HK1115730A1 (en) Selection and use of lactic acid bacteria for reducing inflammation in mammals
FR2953407B1 (fr) Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
EP2386634A4 (en) ENZYMATIC STEROL LATERAL CHAIN CLEAVAGE PROTEIN AND USE THEREOF
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
ZA201005149B (en) Method of increasing the milk and/or meat quantity of silage-fed animals
HK1173182A1 (en) Proliferation-enhancing agent and or survivability-improving agent for lactic acid bacterium belonging to genus lactobacillus
EP2418961A4 (en) MILK OLIGOSACCHARIDE COMPOSITION AND ITS USE IN THE TREATMENT OF INFECTIONS IN ANIMALS
ZA201105179B (en) Selection of animals for desired milk and/or tissue profile
PL1998747T3 (pl) Zastosowanie fermentowanego produktu mlecznego do pielęgnacji skóry
EP2480242A4 (en) PYROLOUSIC TISSUE AND / OR PYROLOUS BACTERIA ISOLATED LIPOPOLYSACCHARIDE AND USES THEREOF
EP2190990A4 (en) PTHRP, its isoforms and antagonist for the diagnosis and treatment of diseases